Evidence map›Paper›PMID 19578366›Full record

ArticleNature genetics2009

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

Margaret Wrensch, Robert B Jenkins, Jeffrey S Chang, Ru-Fang Yeh, Yuanyuan Xiao, Paul A Decker, Karla V Ballman, Mitchel Berger, Jan C Buckner, Susan Chang and 18 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 323 papers, 21 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
323citing papers in PubMed, 21 pooled it
39.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

323 citing papers in PubMed, 21 syntheses or guidelines pooled it, 511 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. The role of the RTEL1 rs2297440 polymorphism in the risk of glioma development: a meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2016
    Pooled it
  13. Pooled it
  14. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.Mammalian genome : official journal of the International Mammalian Genome Society · 2016
    Pooled it
  15. Pooled it
  16. Pooled it
  17. Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Pooled it
  18. Pooled it
  19. Pooled it
  20. The effects of p53 Arg72Pro polymorphism on glioma susceptibility: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it

263 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 4 institutions in 1 country.

Margaret WrenschDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA. margaret.wrensch@ucsf.edu
Robert B Jenkins
Jeffrey S Chang
Ru-Fang Yeh
Yuanyuan Xiao
Paul A Decker
Karla V Ballman
Mitchel Berger
Jan C Buckner
Susan Chang
Caterina Giannini
Chandralekha Halder
Thomas M Kollmeyer
Matthew L Kosel
Daniel H LaChance
Lucie McCoy
Brian P O'Neill
Joe Patoka
Alexander R Pico
Michael Prados
Charles Quesenberry
Terri Rice
Amanda L Rynearson
Ivan Smirnov
Tarik Tihan
Joe Wiemels
Ping Yang
John K Wiencke
Mayo Clinic · USUniversity of California, San Francisco · USNeurological Surgery · USKaiser Permanente · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
Targeted MV-CEA as a Potent Antitumor Agent against GBMP50CA108961 · NCI · MAYO CLINIC ROCHESTER · PI O'NEILL, BRIAN PATRICK · 2004 to 2015
$22.5M
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMAR01CA052689 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIENCKE, JOHN K., WRENSCH, MARGARET R. · 1991 to 2015
$20.5M
Training in Molecular& Genetic Epidemiology of CancerR25CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2005 to 2018
$6.5M
Identification of 9p and 20q Germline Alterations in Glioblastoma PathogenesisRC1NS068222 · NINDS · MAYO CLINIC ROCHESTER · PI JENKINS, ROBERT B. · 2009 to 2010
$984k
NCI NIH HHS P30 CA015083NCI NIH HHS P30 CA15083NCI NIH HHS P50 CA097257NCI NIH HHS P50CA097257NCI NIH HHS P50 CA108961NCI NIH HHS R01 CA052689NCI NIH HHS R01CA52689NCI NIH HHS R25 CA 112355NCI NIH HHS R25 CA112355NINDS NIH HHS RC1 NS068222
6 · The paper itself

Abstract

The causes of glioblastoma and other gliomas remain obscure. To discover new candidate genes influencing glioma susceptibility, we conducted a principal component-adjusted genome-wide association study (GWAS) of 275,895 autosomal variants among 692 adult high-grade glioma cases (622 from the San Francisco Adult Glioma Study (AGS) and 70 from the Cancer Genome Atlas (TCGA)) and 3,992 controls (602 from AGS and 3,390 from Illumina iControlDB (iControls)). For replication, we analyzed the 13 SNPs with P < 10(-6) using independent data from 176 high-grade glioma cases and 174 controls from the Mayo Clinic. On 9p21, rs1412829 near CDKN2B had discovery P = 3.4 x 10(-8), replication P = 0.0038 and combined P = 1.85 x 10(-10). On 20q13.3, rs6010620 intronic to RTEL1 had discovery P = 1.5 x 10(-7), replication P = 0.00035 and combined P = 3.40 x 10(-9). For both SNPs, the direction of association was the same in discovery and replication phases.

Indexed as

Genetic Predisposition to DiseaseAdultCase-Control StudiesChromosome MappingChromosomes, Human, Pair 9Cyclin-Dependent Kinase Inhibitor p15DNA HelicasesGenome, HumanGenome-Wide Association StudyGliomaHaplotypesHumansModels, GeneticPolymorphism, Single NucleotidePrincipal Component AnalysisRegression AnalysisCDKN2B protein, humanCyclin-Dependent Kinase Inhibitor p15DNA HelicasesRTEL1 protein, human

Identifiers

PMID19578366
PMCPMC2923561
OpenAlexW2133980633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.